1 / 6

UofL and Dataseam A Win-Win for Kentucky

UofL and Dataseam A Win-Win for Kentucky. James R. Ramsey, Ph.D. President University of Louisville. Did you know?. A partnership between K-12, higher education and an entrepreneurial company

elisa
Download Presentation

UofL and Dataseam A Win-Win for Kentucky

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. UofL and DataseamA Win-Win for Kentucky James R. Ramsey, Ph.D. President University of Louisville

  2. Did you know? • A partnership between K-12, higher education and an entrepreneurial company • A university sending its top scientists to school districts to talk about the importance of math and science • Efficient use of resources, specifically using computer capacity in the schools to do cancer research

  3. Did you know? • Creating new cancer drugs that have been licensed to a private company – Advanced Cancer Therapeutics – that is providing the capital to help move these drugs through clinical trials to the market • Great legislative support • Student financial aid

  4. Sounds Pretty Good! • It’s what we call our “DataSeam project.” • House Bill One – Postsecondary Education

  5. Benefit to School Districts

  6. Benefits to Kentucky DATASEAM: UofL CONNECTS THE DOTS FOR KENTUCKY $8 MILLION IN SAVINGS TO UofL SCHOLARSHIPS FOR ENTERING UofL DR. JOHN TRENT HARNESSES SCHOOL COMPUTERS UofL DATASEAM FINDING ANSWERS 300 TIMES FASTER STEM EDUCATION SAVINGS TO SCHOOL DISTRICTS TWO DRUGS MOVING INTO CLINCIAL TRIAL 4-IPP 3PO Advanced Cancer Therapeutics

More Related